Kite, a Gilead Company , today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the previous ...
Researchers have used advanced microscopy and computational modeling to show how herpesvirus infection affects host-cell nucleus structure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results